We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 and trading update

23 Mar 2020 16:40

RNS Number : 2694H
Nucleus Financial Group PLC
23 March 2020
 

23 March 2020

Nucleus Financial Group plc

('Nucleus' or the 'Company')

FCA announcement re temporary moratorium on release of preliminary results

Covid-19 and trading update

The Company notes the FCA's guidance on 21 March 2020 requesting that listed companies delay the announcement of preliminary results for at least two weeks due to the challenges caused by the Covid-19 crisis. Consequently, while Nucleus intended to announce its audited results for the year ended 31 December 2019 on 24 March 2020, the Company will observe the FCA's request and will defer the publication of its results.

Further to the Company's announcement on 31 January 2020, the positive inflow momentum from Q4 continued into 2020, and there has been limited impact from Covid-19 on flows to date. To end-February, year to date gross inflows were up 35% and net inflows were up 132% on the equivalent period in 2019, while in March both gross and net inflows continue to be well ahead of the prior year. However, the value of most asset classes has fallen considerably in March, and, as the significant uncertainty continues, it is too early to estimate the impact of the pandemic on Nucleus' performance. Notwithstanding this uncertainty, the group has a robust capital structure and solvency position (with £11.4m of capital in excess of the pillar I minimum regulatory capital requirement), high conversion rate of profit to cash, no borrowings and available liquidity (including £18.5m of cash and cash equivalents at the end of the financial year).

The Company's highest priority is the health and wellbeing of its people, users and customers and it is taking every possible action to adapt to the situation. The Company remains in continual dialogue with users and material service providers. The platform remains fully operational and the vast majority of Nucleus' staff are successfully working remotely with no meaningful impact on service at present.

The Company's performance in respect of the 2019 financial year is expected to be in line with market consensus.

The Company will release a further announcement with regard to the timing of the publication of its audited financial statements as soon as practicable.

 

~ Ends ~

For further information please contact:

Nucleus

David Ferguson, Founder and CEO Tel: +44 (0)13 1226 9800

Stuart Geard, chief financial officer

 

Shore Capital (Nominated Adviser and Broker)

Hugh Morgan Tel: +44 (0)20 7408 4090

Edward Mansfield

Daniel Bush 

 

Camarco (Media enquiries)

Jennifer Renwick Tel: +44 (0)20 3757 4994

Jake Thomas

 

Notes to Editors

About Nucleus

Nucleus is a wrap platform founded in 2006 by advisers committed to altering the balance of power in the industry by putting the customer centre stage. It provides independent wrap platform services to 1,442 active adviser users and works with more than 880 financial adviser firms as at 31 December 2019. It is responsible for AUA of £16.1bn on behalf of more than 96,000 customers.

The multi award-winning platform offers a range of custody, trading, payment, reporting, fee-handling, research and integration services across a variety of tax wrappers and more than 6,500 asset choices including cash, OEICs, unit trusts, offshore funds, structured products and listed securities, including ETFs and investment trusts. The platform currently facilitates over 1.1 million customer account transactions on average per month.

Nucleus has been awarded a 5-star service rating at the 2019 Financial Adviser Awards and won CoreData's 'Best medium sized platform' for 2019 (and the last eight years), the Schroders 'Platform of the Year' award for 2016, 2017 and 2018 and won 'Best Platform' and 'Platform Innovation' at the 2018 Money Marketing Awards.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFZGZFVFNGGZM
Date   Source Headline
3rd Dec 202011:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
2nd Dec 202012:07 pmRNSStatement regarding a Possible Offer
17th Nov 20207:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSAcquisition of certain assets of OpenWealth
23rd Oct 20207:00 amRNSQ3 2020 AUA update
13th Oct 20201:35 pmRNSDirector/PDMR Shareholding
28th Sep 202012:18 pmRNSDirector/PDMR Shareholding
15th Sep 20209:26 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSInterim Results
14th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20207:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSQ2 2020 AUA update
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jun 202012:10 pmRNSDirector/PDMR Shareholding
20th May 20203:44 pmRNSGrant of long term incentive awards
20th May 20201:14 pmRNSResult of AGM
14th May 20207:00 amRNSDirector/PDMR Shareholding
15th Apr 20204:13 pmRNSNotice of AGM
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSFinal Results
23rd Mar 20204:40 pmRNSCovid-19 and trading update
17th Mar 20202:28 pmRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSNon-Executive Director Changes
13th Feb 20204:15 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSQ4 2019 AUA update
29th Jan 20202:20 pmRNSHolding(s) in Company
15th Jan 20203:43 pmRNSDirector/PDMR Shareholding
16th Dec 20192:37 pmRNSDirector/PDMR Shareholding
22nd Nov 20193:50 pmRNSDirector/PDMR Shareholding
14th Nov 201912:00 pmRNSDirector/PDMR Shareholding
25th Oct 20197:00 amRNSQ3 2019 AUA update
18th Oct 20195:38 pmRNSDirector/PDMR Shareholding
16th Oct 201911:15 amRNSDirector/PDMR Shareholding
17th Sep 20194:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
16th Aug 20197:00 amRNSNotice of Results
15th Aug 20193:58 pmRNSDirector/PDMR Shareholding
26th Jul 20197:00 amRNSQ2 2019 AUA update
16th Jul 20199:00 amRNSDirector/PDMR Shareholding
14th Jun 20194:48 pmRNSDirector/PDMR Shareholding
23rd May 201911:35 amRNSResult of AGM
17th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSQ1 2019 AUA update
16th Apr 20191:58 pmRNSDirector/PDMR Shareholding
11th Apr 20192:24 pmRNSPosting of Annual Report and Notice of AGM
4th Apr 20198:20 amRNSHolding(s) in Company
3rd Apr 20191:50 pmRNSGrant of long term incentive awards to PDMRs
2nd Apr 20197:00 amRNSPreliminary results
14th Mar 20194:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.